REGENESANCE B.V.
6Patents
6Active
6Granted
47Portfolio score
Filing activity: Oct 10, 2007 → Feb 14, 2023 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8703136B2 | Complement inhibition for improved nerve regeneration | Human Necessities | 26 | Active |
| US10675348B2 | Antibodies that bind human C6 and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US12194091B2 | Antibodies that bind human C6 and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11590222B2 | Antibodies that bind human C6 and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US9089555B2 | Complement antagonists and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US8703730B2 | Complement antagonists and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.